Premier Alternatives

Coding Bio

Drug Discovery · Oxford, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. Coding Bio is based in Oxford, United Kingdom and was founded in 2020. It was valued at $6.6 million at its seed round in Sep 2023, the last priced event on record. It has raised $3.6 million across 1 recorded round; the latest was a $3.6 million seed round in Sep 2023.

PMV mark · valuation
$6.6M
Oct 2026
Priced at
its seed round
Sep 2023
Total raised
$3.6M
Last round
Seed Round
Sep 2023

Coding Bio key facts

as of Oct 2026
  • Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors.
  • Coding Bio is valued at approximately $6.6M as of Oct 2026, set at its seed round, Sep 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $3.6M across 1 recorded rounds; the latest was Seed Round ($3.6M) in Sep 2023.
  • Notable investors include Metaplanet Holdings, Global Founders Capital, 2048 Ventures, BoxOne Ventures, The Venture Collective — 15 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$6.6M

Valued at $6.6M at its seed round, Sep 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Coding Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Coding Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Coding Bio funding rounds

1 rounds
Sep 2023Seed Round$3.6M▮
Full funding history →

Coding Bio valuation

Coding Bio was valued at $6.6 million at its seed round in Sep 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Coding Bio raised?

Coding Bio has raised $3.6 million across 1 recorded round since 2023. The largest was a $3.6 million seed round in Sep 2023.

Coding Bio investors

15 investors are on record for Coding Bio, including Metaplanet Holdings, Global Founders Capital, 2048 Ventures and BoxOne Ventures. The seed round in Sep 2023 drew 11 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Ancilia Bio ($28 million), PAhR Therapeutics ($25 million) and Valink Therapeutics ($12.6 million).

About Coding Bio

Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. The company's platform uses artificial intelligence to design cell therapies through automation and computation, enabling patients to recover from illness with the help of curative therapeutics.

Industry
Drug Discovery
Sector
Healthcare
HQ
Oxford, United Kingdom
Founded
2020
Employees
19
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.